p53

For this the sera were tested using the commercial Euroimmun Anti-MERS CoV ELISA (IgG) kit in which recombinant MERS CoV spike protein is provided as the reference antigen

by globalhealth
June 29, 2022

For this the sera were tested using the commercial Euroimmun Anti-MERS CoV ELISA (IgG) kit in which recombinant MERS CoV spike protein is provided as… Read More »For this the sera were tested using the commercial Euroimmun Anti-MERS CoV ELISA (IgG) kit in which recombinant MERS CoV spike protein is provided as the reference antigen

The expression of cytomegalovirus (CMV) antigens in GBM presents a distinctive possibility to target these viral proteins for tumor immunotherapy

by globalhealth
February 17, 2022

The expression of cytomegalovirus (CMV) antigens in GBM presents a distinctive possibility to target these viral proteins for tumor immunotherapy. capability to elicit CMV pp65-particular… Read More »The expression of cytomegalovirus (CMV) antigens in GBM presents a distinctive possibility to target these viral proteins for tumor immunotherapy

D) HBEC3 and HBEC3-p53KD-K-Rasv12 cells were infected lentiviruses encoding shRNA BRMS1 (BRMS1 KD) or shRNA control (Control)

by globalhealth
December 31, 2021

D) HBEC3 and HBEC3-p53KD-K-Rasv12 cells were infected lentiviruses encoding shRNA BRMS1 (BRMS1 KD) or shRNA control (Control). of HBEC3-p53KD-K-Rasv12 cells +/-BRMS1 KD with and without… Read More »D) HBEC3 and HBEC3-p53KD-K-Rasv12 cells were infected lentiviruses encoding shRNA BRMS1 (BRMS1 KD) or shRNA control (Control)